Purple biotech reports first quarter 2025 financial results

Final cm24 phase 2 data presented at aacr annual meeting 2025, strengthening patient selection strategy for cm24 phase 2b study planned to be initiated in second half of 2025
PPBT Ratings Summary
PPBT Quant Ranking